VERTEX PHARMACEUTICALS INC / MA Insider Trading for February 2020

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for February 2020.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	WAGNER CHARLES F JR	EVP and CFO	Payment of Exercise	F	239.23	542	129,663	17,274	17.8 K to 17.3 K (-3.04 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	237.81	240	57,074	12,738	13 K to 12.7 K (-1.85 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	235.39	160	37,662	12,978	13.1 K to 13 K (-1.22 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	234.43	240	56,263	13,138	13.4 K to 13.1 K (-1.79 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	232.43	80	18,594	13,378	13.5 K to 13.4 K (-0.59 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	231.82	160	37,091	13,458	13.6 K to 13.5 K (-1.17 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	229.57	416	95,501	13,618	14 K to 13.6 K (-2.96 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Payment of Exercise	F	239.23	1,036	247,842	14,034	15.1 K to 14 K (-6.87 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	238.40	150	35,760	14,932	15.1 K to 14.9 K (-0.99 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	236.85	90	21,317	15,082	15.2 K to 15.1 K (-0.59 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	235.49	150	35,324	15,172	15.3 K to 15.2 K (-0.98 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	234.50	150	35,175	15,322	15.5 K to 15.3 K (-0.97 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	232.40	120	27,888	15,472	15.6 K to 15.5 K (-0.77 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	231.17	137	31,670	15,592	15.7 K to 15.6 K (-0.87 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	229.66	283	64,994	15,729	16 K to 15.7 K (-1.77 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Payment of Exercise	F	239.23	864	206,695	16,012	16.9 K to 16 K (-5.12 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	238.33	540	128,698	32,915	33.5 K to 32.9 K (-1.61 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	236.63	180	42,593	33,455	33.6 K to 33.5 K (-0.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	235.75	360	84,870	33,635	34 K to 33.6 K (-1.06 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	234.56	533	125,020	33,995	34.5 K to 34 K (-1.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	233.18	90	20,986	34,528	34.6 K to 34.5 K (-0.26 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	232.62	450	104,679	34,618	35.1 K to 34.6 K (-1.28 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	230.98	270	62,365	35,068	35.3 K to 35.1 K (-0.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	230.00	953	219,190	35,338	36.3 K to 35.3 K (-2.63 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Payment of Exercise	F	239.23	3,156	755,010	36,291	39.4 K to 36.3 K (-8.00 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	238.30	480	114,384	26,838	27.3 K to 26.8 K (-1.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	236.26	320	75,603	27,318	27.6 K to 27.3 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	234.77	640	150,253	27,638	28.3 K to 27.6 K (-2.26 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	232.89	320	74,525	28,278	28.6 K to 28.3 K (-1.12 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	231.62	330	76,435	28,598	28.9 K to 28.6 K (-1.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	230.07	938	215,806	28,928	29.9 K to 28.9 K (-3.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	239.23	2,416	577,980	29,866	32.3 K to 29.9 K (-7.48 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	238.33	1,680	400,394	92,581	94.3 K to 92.6 K (-1.78 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	236.63	560	132,513	94,261	94.8 K to 94.3 K (-0.59 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	235.53	1,210	284,991	94,821	96 K to 94.8 K (-1.26 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	234.49	1,640	384,564	96,031	97.7 K to 96 K (-1.68 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	232.96	1,017	236,920	97,671	98.7 K to 97.7 K (-1.03 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	231.76	1,050	243,348	98,688	99.7 K to 98.7 K (-1.05 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	230.40	1,120	258,048	99,738	100.9 K to 99.7 K (-1.11 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	229.77	2,273	522,267	100,858	103.1 K to 100.9 K (-2.20 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Payment of Exercise	F	239.23	8,410	2,011,924	103,131	111.5 K to 103.1 K (-7.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	239.13	111	26,543	26,626	26.7 K to 26.6 K (-0.42 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	238.28	420	100,078	26,737	27.2 K to 26.7 K (-1.55 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	236.71	320	75,747	27,157	27.5 K to 27.2 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	235.36	340	80,022	27,477	27.8 K to 27.5 K (-1.22 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	234.41	660	154,711	27,817	28.5 K to 27.8 K (-2.32 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	232.35	440	102,234	28,477	28.9 K to 28.5 K (-1.52 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	230.88	450	103,896	28,917	29.4 K to 28.9 K (-1.53 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	229.72	893	205,140	29,367	30.3 K to 29.4 K (-2.95 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Payment of Exercise	F	239.23	2,898	693,289	30,260	33.2 K to 30.3 K (-8.74 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Bozic Carmen	EVP, GMDA	Payment of Exercise	F	239.23	216	51,674	14,302	14.5 K to 14.3 K (-1.49 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.33	632	150,625	35,179	35.8 K to 35.2 K (-1.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	236.88	20	4,738	35,811	35.8 K to 35.8 K (-0.06 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	236.36	420	99,271	35,831	36.3 K to 35.8 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	235.14	540	126,976	36,251	36.8 K to 36.3 K (-1.47 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	234.08	420	98,314	36,791	37.2 K to 36.8 K (-1.13 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	232.35	360	83,646	37,211	37.6 K to 37.2 K (-0.96 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	230.85	432	99,727	37,571	38 K to 37.6 K (-1.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	229.78	810	186,122	38,003	38.8 K to 38 K (-2.09 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	239.23	2,898	693,289	38,813	41.7 K to 38.8 K (-6.95 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	238.33	480	114,398	28,902	29.4 K to 28.9 K (-1.63 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	236.80	160	37,888	29,382	29.5 K to 29.4 K (-0.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	235.53	280	65,948	29,542	29.8 K to 29.5 K (-0.94 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	234.52	574	134,614	29,822	30.4 K to 29.8 K (-1.89 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	232.51	400	93,004	30,396	30.8 K to 30.4 K (-1.30 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	230.77	400	92,308	30,796	31.2 K to 30.8 K (-1.28 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	229.72	734	168,614	31,196	31.9 K to 31.2 K (-2.30 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Payment of Exercise	F	239.23	2,416	577,980	31,930	34.3 K to 31.9 K (-7.03 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	245.74	202	49,639	16,876	17.1 K to 16.9 K (-1.18 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	245.00	280	68,600	17,078	17.4 K to 17.1 K (-1.61 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	243.85	202	49,258	17,358	17.6 K to 17.4 K (-1.15 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	242.80	640	155,392	17,560	18.2 K to 17.6 K (-3.52 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	241.95	240	58,068	18,200	18.4 K to 18.2 K (-1.30 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Payment of Exercise	F	241.50	1,248	301,392	18,440	19.7 K to 18.4 K (-6.34 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.82	249	61,209	39,447	39.7 K to 39.4 K (-0.63 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.15	720	176,508	39,696	40.4 K to 39.7 K (-1.78 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	244.08	540	131,803	40,416	41 K to 40.4 K (-1.32 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	242.85	1,260	305,991	40,956	42.2 K to 41 K (-2.98 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	242.04	720	174,269	42,216	42.9 K to 42.2 K (-1.68 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Payment of Exercise	F	241.50	3,262	787,773	42,936	46.2 K to 42.9 K (-7.06 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	245.52	694	170,391	32,282	33 K to 32.3 K (-2.10 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	244.64	416	101,770	32,976	33.4 K to 33 K (-1.25 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	243.59	560	136,410	33,392	34 K to 33.4 K (-1.65 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	242.64	1,098	266,419	33,952	35.1 K to 34 K (-3.13 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	241.75	360	87,030	35,050	35.4 K to 35.1 K (-1.02 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	241.50	2,496	602,784	35,410	37.9 K to 35.4 K (-6.58 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	245.75	129	31,702	33,158	33.3 K to 33.2 K (-0.39 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	244.94	260	63,684	33,287	33.5 K to 33.3 K (-0.78 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	243.76	134	32,664	33,547	33.7 K to 33.5 K (-0.40 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	242.62	540	131,015	33,681	34.2 K to 33.7 K (-1.58 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	241.71	120	29,005	34,221	34.3 K to 34.2 K (-0.35 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Payment of Exercise	F	241.50	944	227,976	34,341	35.3 K to 34.3 K (-2.68 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.76	377	92,652	41,711	42.1 K to 41.7 K (-0.90 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.04	580	142,123	42,088	42.7 K to 42.1 K (-1.36 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	243.76	400	97,504	42,668	43.1 K to 42.7 K (-0.93 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.91	1,011	245,582	43,068	44.1 K to 43.1 K (-2.29 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.08	760	183,981	44,079	44.8 K to 44.1 K (-1.69 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	241.50	2,496	602,784	44,839	47.3 K to 44.8 K (-5.27 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	245.57	556	136,537	34,346	34.9 K to 34.3 K (-1.59 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	244.87	632	154,758	34,902	35.5 K to 34.9 K (-1.78 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	243.66	530	129,140	35,534	36.1 K to 35.5 K (-1.47 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	242.62	1,010	245,046	36,064	37.1 K to 36.1 K (-2.72 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	241.80	400	96,720	37,074	37.5 K to 37.1 K (-1.07 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Payment of Exercise	F	241.50	2,496	602,784	37,474	40 K to 37.5 K (-6.24 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	248.45	4,609	1,145,106	132,540	137.1 K to 132.5 K (-3.36 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	247.49	7,533	1,864,342	137,149	144.7 K to 137.1 K (-5.21 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	246.27	14,433	3,554,415	144,682	159.1 K to 144.7 K (-9.07 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	245.37	14,024	3,441,069	159,115	173.1 K to 159.1 K (-8.10 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	244.56	4,124	1,008,565	173,139	177.3 K to 173.1 K (-2.33 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	243.37	2,800	681,436	177,263	180.1 K to 177.3 K (-1.56 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Payment of Exercise	F	240.95	36,755	8,856,117	180,063	216.8 K to 180.1 K (-16.95 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	247.93	1,102	273,219	19,688	20.8 K to 19.7 K (-5.30 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	246.84	1,120	276,461	20,790	21.9 K to 20.8 K (-5.11 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	245.89	1,700	418,013	21,910	23.6 K to 21.9 K (-7.20 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	244.90	1,560	382,044	23,610	25.2 K to 23.6 K (-6.20 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	243.59	380	92,564	25,170	25.6 K to 25.2 K (-1.49 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Payment of Exercise	F	240.95	4,673	1,125,959	25,550	30.2 K to 25.6 K (-15.46 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	248.73	400	99,492	46,198	46.6 K to 46.2 K (-0.86 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	247.98	2,103	521,502	46,598	48.7 K to 46.6 K (-4.32 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	246.88	1,821	449,568	48,701	50.5 K to 48.7 K (-3.60 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.99	4,320	1,062,677	50,522	54.8 K to 50.5 K (-7.88 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.05	3,426	839,541	54,842	58.3 K to 54.8 K (-5.88 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	243.53	1,000	243,530	58,268	59.3 K to 58.3 K (-1.69 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Payment of Exercise	F	240.95	12,215	2,943,204	59,268	71.5 K to 59.3 K (-17.09 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	248.52	1,344	334,011	37,906	39.3 K to 37.9 K (-3.42 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	247.62	2,499	618,802	39,250	41.7 K to 39.3 K (-5.99 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	246.52	3,783	932,585	41,749	45.5 K to 41.7 K (-8.31 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	245.62	6,232	1,530,704	45,532	51.8 K to 45.5 K (-12.04 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	244.67	2,102	514,296	51,764	53.9 K to 51.8 K (-3.90 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	243.42	922	224,433	53,866	54.8 K to 53.9 K (-1.68 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	240.95	13,458	3,242,705	54,788	68.2 K to 54.8 K (-19.72 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	248.62	486	120,829	47,335	47.8 K to 47.3 K (-1.02 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	247.91	1,863	461,856	47,821	49.7 K to 47.8 K (-3.75 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	246.76	1,770	436,765	49,684	51.5 K to 49.7 K (-3.44 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.93	3,377	830,506	51,454	54.8 K to 51.5 K (-6.16 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	244.99	2,860	700,671	54,831	57.7 K to 54.8 K (-4.96 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	243.76	930	226,697	57,691	58.6 K to 57.7 K (-1.59 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	240.95	8,942	2,154,575	58,621	67.6 K to 58.6 K (-13.24 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	248.50	1,200	298,200	39,970	41.2 K to 40 K (-2.91 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	247.73	2,235	553,677	41,170	43.4 K to 41.2 K (-5.15 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	246.73	3,472	856,647	43,405	46.9 K to 43.4 K (-7.41 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	245.81	5,725	1,407,262	46,877	52.6 K to 46.9 K (-10.88 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	244.89	3,400	832,626	52,602	56 K to 52.6 K (-6.07 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	243.36	1,000	243,360	56,002	57 K to 56 K (-1.75 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Payment of Exercise	F	240.95	13,308	3,206,563	57,002	70.3 K to 57 K (-18.93 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Option Exercise	M	57.27	2,000	114,540	14,306
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	239.96	600	143,976	1,875	2.5 K to 1.9 K (-24.24 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	238.50	200	47,700	2,475	2.7 K to 2.5 K (-7.48 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	237.51	700	166,257	2,675	3.4 K to 2.7 K (-20.74 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	236.29	200	47,258	3,375	3.6 K to 3.4 K (-5.59 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	234.84	300	70,452	3,575	3.9 K to 3.6 K (-7.74 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Buy	M	57.27	2,000	114,540	3,875	1.9 K to 3.9 K (+106.67 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	WAGNER CHARLES F JR	EVP and CFO	Grant	A	0.00	10,323	0	17,816	7.5 K to 17.8 K (+137.77 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	WAGNER CHARLES F JR	EVP and CFO	Grant	A	0.00	3,698	0	7,493	3.8 K to 7.5 K (+97.44 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Option Exercise	M	155.57	408	63,473	3,261
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Option Exercise	M	187.53	559	104,829	6,704
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	242.47	66	16,003	16,946	17 K to 16.9 K (-0.39 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	240.70	90	21,663	17,012	17.1 K to 17 K (-0.53 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	239.68	240	57,523	17,102	17.3 K to 17.1 K (-1.38 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	238.77	571	136,338	17,342	17.9 K to 17.3 K (-3.19 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Buy	M	155.57	408	63,473	17,913	17.5 K to 17.9 K (+2.33 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Buy	M	187.53	559	104,829	17,505	16.9 K to 17.5 K (+3.30 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Grant	A	0.00	6,194	0	16,946	10.8 K to 16.9 K (+57.61 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Grant	A	0.00	3,500	0	10,752	7.3 K to 10.8 K (+48.26 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Option Exercise	M	187.53	466	87,389	5,587
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	242.47	31	7,517	30,223	30.3 K to 30.2 K (-0.10 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	240.46	92	22,122	30,254	30.3 K to 30.3 K (-0.30 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	238.73	343	81,884	30,346	30.7 K to 30.3 K (-1.12 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Buy	M	187.53	466	87,389	30,689	30.2 K to 30.7 K (+1.54 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Grant	A	0.00	3,226	0	30,223	27 K to 30.2 K (+11.95 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Grant	A	0.00	2,918	0	26,997	24.1 K to 27 K (+12.12 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Grant	A	0.00	6,320	0	24,079	17.8 K to 24.1 K (+35.59 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Grant	A	0.00	10,323	0	71,483	61.2 K to 71.5 K (+16.88 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Grant	A	0.00	9,800	0	61,160	51.4 K to 61.2 K (+19.08 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Grant	A	0.00	15,170	0	51,360	36.2 K to 51.4 K (+41.92 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Option Exercise	M	155.57	1,223	190,262	9,783
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Option Exercise	M	187.53	1,303	244,352	15,642
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	242.47	154	37,340	68,246	68.4 K to 68.2 K (-0.23 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	240.79	300	72,237	68,400	68.7 K to 68.4 K (-0.44 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	239.58	585	140,154	68,700	69.3 K to 68.7 K (-0.84 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	238.77	1,487	355,051	69,285	70.8 K to 69.3 K (-2.10 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Buy	M	155.57	1,223	190,262	70,772	69.5 K to 70.8 K (+1.76 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Buy	M	187.53	1,303	244,352	69,549	68.2 K to 69.5 K (+1.91 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Grant	A	0.00	10,323	0	68,246	57.9 K to 68.2 K (+17.82 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Grant	A	0.00	8,166	0	57,923	49.8 K to 57.9 K (+16.41 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Grant	A	0.00	18,204	0	49,757	31.6 K to 49.8 K (+57.69 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Bozic Carmen	EVP, GMDA	Grant	A	0.00	10,323	0	14,518	4.2 K to 14.5 K (+246.08 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Bozic Carmen	EVP, GMDA	Grant	A	0.00	2,098	0	4,195	2.1 K to 4.2 K (+100.05 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	155.57	1,223	190,262	9,783
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	187.53	1,564	293,297	18,770
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.47	171	41,462	67,563	67.7 K to 67.6 K (-0.25 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	241.08	150	36,162	67,734	67.9 K to 67.7 K (-0.22 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	240.53	230	55,322	67,884	68.1 K to 67.9 K (-0.34 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	239.47	725	173,616	68,114	68.8 K to 68.1 K (-1.05 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.71	1,511	360,691	68,839	70.4 K to 68.8 K (-2.15 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	155.57	1,223	190,262	70,350	69.1 K to 70.4 K (+1.77 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	187.53	1,564	293,297	69,127	67.6 K to 69.1 K (+2.31 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	12,387	0	67,563	55.2 K to 67.6 K (+22.45 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	9,800	0	55,176	45.4 K to 55.2 K (+21.60 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	12,136	0	45,376	33.2 K to 45.4 K (+36.51 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Option Exercise	M	155.57	1,223	190,262	9,783
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Option Exercise	M	187.53	1,303	244,352	15,642
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	242.47	154	37,340	70,310	70.5 K to 70.3 K (-0.22 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	240.82	280	67,430	70,464	70.7 K to 70.5 K (-0.40 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	239.63	630	150,967	70,744	71.4 K to 70.7 K (-0.88 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	238.74	1,462	349,038	71,374	72.8 K to 71.4 K (-2.01 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	M	155.57	1,223	190,262	72,836	74.1 K to 72.8 K (-1.65 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	M	187.53	1,303	244,352	71,613	72.9 K to 71.6 K (-1.79 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Grant	A	0.00	12,387	0	70,310	57.9 K to 70.3 K (+21.39 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Grant	A	0.00	8,166	0	57,923	49.8 K to 57.9 K (+16.41 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Grant	A	0.00	18,204	0	49,757	31.6 K to 49.8 K (+57.69 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Option Exercise	M	57.27	2,000	114,540	18,306
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Option Exercise	M	57.27	3,028	173,414	20,306
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	243.78	332	80,935	1,875	2.2 K to 1.9 K (-15.04 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	243.13	637	154,874	2,207	2.8 K to 2.2 K (-22.40 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	242.03	629	152,237	2,844	3.5 K to 2.8 K (-18.11 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	240.59	402	96,717	3,473	3.9 K to 3.5 K (-10.37 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Buy	M	57.27	2,000	114,540	3,875	1.9 K to 3.9 K (+106.67 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	241.01	112	26,993	1,875	2 K to 1.9 K (-5.64 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	239.81	1,026	246,045	1,987	3 K to 2 K (-34.05 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	238.94	353	84,346	3,013	3.4 K to 3 K (-10.49 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	236.99	233	55,219	3,366	3.6 K to 3.4 K (-6.47 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	236.19	161	38,027	3,599	3.8 K to 3.6 K (-4.28 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	235.15	115	27,042	3,760	3.9 K to 3.8 K (-2.97 %)
Feb 06 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Buy	M	57.27	3,028	173,414	3,875	847 to 3.9 K (+357.50 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Option Exercise	M	86.52	809	69,995	3,236
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Option Exercise	M	91.05	1,290	117,455	0
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	232.75	210	48,878	17,759	18 K to 17.8 K (-1.17 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	231.46	630	145,820	17,969	18.6 K to 18 K (-3.39 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	231.03	809	186,903	18,599	19.4 K to 18.6 K (-4.17 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	230.28	240	55,267	19,408	19.6 K to 19.4 K (-1.22 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	228.91	210	48,071	19,648	19.9 K to 19.6 K (-1.06 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Buy	M	86.52	809	69,995	19,858	19 K to 19.9 K (+4.25 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Buy	M	91.05	1,290	117,455	19,049	17.8 K to 19 K (+7.26 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Option Exercise	M	86.52	1,941	167,935	7,767
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Option Exercise	M	91.05	2,156	196,304	0
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	232.87	400	93,148	36,190	36.6 K to 36.2 K (-1.09 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	231.92	1,177	272,970	36,590	37.8 K to 36.6 K (-3.12 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	231.25	1,306	302,013	37,767	39.1 K to 37.8 K (-3.34 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	230.07	714	164,270	39,073	39.8 K to 39.1 K (-1.79 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	228.89	500	114,445	39,787	40.3 K to 39.8 K (-1.24 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Buy	M	86.52	1,941	167,935	40,287	38.3 K to 40.3 K (+5.06 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Buy	M	91.05	2,156	196,304	38,346	36.2 K to 38.3 K (+5.96 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Option Exercise	M	86.52	2,330	201,592	9,320
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Option Exercise	M	91.05	1,796	163,526	0
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	232.88	470	109,454	31,553	32 K to 31.6 K (-1.47 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	231.67	2,122	491,604	32,023	34.1 K to 32 K (-6.21 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	230.60	785	181,021	34,145	34.9 K to 34.1 K (-2.25 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	229.35	749	171,783	34,930	35.7 K to 34.9 K (-2.10 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Buy	M	86.52	2,330	201,592	35,679	33.3 K to 35.7 K (+6.99 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Buy	M	91.05	1,796	163,526	33,349	31.6 K to 33.3 K (+5.69 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Option Exercise	M	86.52	1,941	167,935	7,767
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Option Exercise	M	91.05	2,156	196,304	0
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	232.87	400	93,148	36,190	36.6 K to 36.2 K (-1.09 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	231.92	1,177	272,970	36,590	37.8 K to 36.6 K (-3.12 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	231.25	1,306	302,013	37,767	39.1 K to 37.8 K (-3.34 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	230.07	714	164,270	39,073	39.8 K to 39.1 K (-1.79 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	228.89	500	114,445	39,787	40.3 K to 39.8 K (-1.24 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Buy	M	86.52	1,941	167,935	40,287	38.3 K to 40.3 K (+5.06 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Buy	M	91.05	2,156	196,304	38,346	36.2 K to 38.3 K (+5.96 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Option Exercise	M	86.52	2,330	201,592	9,320
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Option Exercise	M	91.05	1,796	163,526	0
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	232.88	470	109,454	31,553	32 K to 31.6 K (-1.47 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	231.67	2,122	491,604	32,023	34.1 K to 32 K (-6.21 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	230.60	785	181,021	34,145	34.9 K to 34.1 K (-2.25 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	229.35	749	171,783	34,930	35.7 K to 34.9 K (-2.10 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Buy	M	86.52	2,330	201,592	35,679	33.3 K to 35.7 K (+6.99 %)
Feb 05 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Buy	M	91.05	1,796	163,526	33,349	31.6 K to 33.3 K (+5.69 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Option Exercise	M	86.52	2,330	201,592	9,320
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Option Exercise	M	187.53	3,909	733,055	16,945
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	233.03	400	93,212	31,553	32 K to 31.6 K (-1.25 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	231.84	1,500	347,760	31,953	33.5 K to 32 K (-4.48 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	231.20	1,350	312,120	33,453	34.8 K to 33.5 K (-3.88 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	230.02	612	140,772	34,803	35.4 K to 34.8 K (-1.73 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	229.07	574	131,486	35,415	36 K to 35.4 K (-1.59 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Buy	M	86.52	2,330	201,592	35,989	33.7 K to 36 K (+6.92 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	231.21	1,344	310,746	33,659	35 K to 33.7 K (-3.84 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	238.65	3,909	932,883	35,003	38.9 K to 35 K (-10.05 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Buy	M	187.53	3,909	733,055	38,912	35 K to 38.9 K (+11.17 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Option Exercise	M	187.53	1,396	261,792	6,053
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	238.65	1,396	333,155	17,759	19.2 K to 17.8 K (-7.29 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Buy	M	187.53	1,396	261,792	19,155	17.8 K to 19.2 K (+7.86 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	232.69	200	46,538	847	1 K to 847 (-19.10 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	231.70	956	221,505	1,047	2 K to 1 K (-47.73 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	230.69	421	97,120	2,003	2.4 K to 2 K (-17.37 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	229.39	423	97,032	2,424	2.8 K to 2.4 K (-14.86 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	233.37	200	46,674	2,847	3 K to 2.8 K (-6.56 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	232.51	300	69,753	3,047	3.3 K to 3 K (-8.96 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	230.04	100	23,004	3,347	3.4 K to 3.3 K (-2.90 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	227.54	171	38,909	3,447	3.6 K to 3.4 K (-4.73 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	226.64	823	186,525	3,618	4.4 K to 3.6 K (-18.53 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	225.10	206	46,371	4,441	4.6 K to 4.4 K (-4.43 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	224.03	200	44,806	4,647	4.8 K to 4.6 K (-4.13 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,554	134,452	6,213
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	91.05	2,156	196,304	0
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	187.53	4,692	879,891	20,334
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	232.71	540	125,663	33,240	33.8 K to 33.2 K (-1.60 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	231.87	900	208,683	33,780	34.7 K to 33.8 K (-2.60 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	231.16	1,300	300,508	34,680	36 K to 34.7 K (-3.61 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	229.99	530	121,895	35,980	36.5 K to 36 K (-1.45 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	228.90	440	100,716	36,510	37 K to 36.5 K (-1.19 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	M	86.52	1,554	134,452	36,950	38.5 K to 37 K (-4.04 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	M	91.05	2,156	196,304	35,396	37.6 K to 35.4 K (-5.74 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.65	4,692	1,119,746	33,240	37.9 K to 33.2 K (-12.37 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	187.53	4,692	879,891	37,932	33.2 K to 37.9 K (+14.12 %)